Global Pemetrexed Diacid Market Size by Consumption Type, by Cancer Type, by Therapeutic Modality, by Geographic Scope And Forecast

1.1 Market Overview
1.2 Market Segmentation
1.3 Assumptions

2.1 Overview of the Market
2.2 Global Pemetrexed Diacid Market, by Consumption Type (Usd Million)
2.3 Global Pemetrexed Diacid Market, by Cancer Type (Usd Million)
2.4 Global Pemetrexed Diacid Market Shares, by Therapeutic Modalities, 2016 (%)
2.5 Global Pemetrexed Acid Market, by Geography (Usd Million)

3.1 Data Mining
3.2 Secondary Research
3.3 Primary Research
3.4 Subject Matter Expert Advice
3.5 Quality Check
3.6 Final Review
3.7 Validation
3.8 Primary Interviews
3.9 Research Scope and Assumptions
3.10 List of Data Sources

4.1 Market Dynamics
4.1.1 Market Drivers
4.1.1.1 Rising Instances of Lung Cancer
4.1.1.2 Increasing Consumption of Chemotherapy Drugs in Developing Countries
4.1.2 Market Restraints
4.1.2.1 High Cost of Chemotherapy Drug Development
4.1.2.2 Effects of Pemetrexed Diacid
4.1.3 Market Challenges
4.1.3.1 Loss of Patent Exclusivities Giving Rise to Generics
4.2 Porter's Five Force Analysis

5.1 Overview
5.2 in Combination With Cisplatin/Carboplatin
5.3 Supplement

6.1 Overview
6.2 Lung Cancer
6.3 Liver Cancer
6.4 Colorectal Cancer
6.5 Stomach
6.6 Breast
6.7 Others

7.1 Overview
7.2 Chemotherapy
7.3 Immunotherapy
7.4 Other

8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 Uk.
8.3.3 France
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.5 Latin America
8.5.1 Brazil
8.6 Rest of the World

10.1 Eli Lilly and Company
10.1.1 Company Overview
10.1.2 Eli Lilly and Company: Key Facts
10.1.3 Financial Performance
10.1.4 Product Benchmarking
10.1.5 Eli Lilly and Company: SWOT Analysis
10.2 Fresenius Kabi
10.2.1 Company Overview
10.2.2 Fresenius Kabi: Key Facts
10.2.3 Financial Performance
10.2.4 Product Benchmarking
10.2.5 Fresenius Kabi: SWOT Analysis
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Company Overview
10.3.2 Teva Pharmaceutical Industries Ltd.: Key Facts
10.3.3 Financial Performance
10.3.4 Product Benchmarking
10.3.5 Teva Pharmaceutical Industries Ltd.: SWOT Analysis
10.4 Dr Reddy's Laboratories
10.4.1 Company Overview
10.4.2 Dr Reddy's Laboratories: Key Facts
10.4.3 Financial Performance
10.4.4 Product Benchmarking
10.4.5 Dr. Reddy's Laboratories: SWOT Analysis
10.5 Abbott Laboratories
10.5.1 Company Overview
10.5.2 Abbott Laboratories: Key Facts
10.5.3 Financial Performance
10.5.4 Product Benchmarking
10.5.5 Abbott Laboratories: SWOT Analysis
10.6 Cadila Healthcare Ltd.
10.6.1 Company Overview
10.6.2 Cadila Healthcare: Key Facts
10.6.3 Financial Performance
10.6.4 Product Benchmarking
10.7 Accord Healthcare Inc.
10.7.1 Company Overview
10.7.2 Accord Healthcare Inc.: Key Facts
10.7.3 Financial Performance (Intas Pharmaceuticals Ltd.)
10.7.4 Product Benchmarking
10.8 Qilu Pharma Co Ltd
10.8.1 Company Overview
10.8.2 Qilu Pharma Co Ltd: Key Facts
10.8.3 Product Benchmarking
10.9 Accure Labs Pvt. Ltd
10.9.1 Company Overview
10.9.2 Accure Labs Pvt. Ltd: Key Facts
10.9.3 Product Benchmarking
10.10 Pfizer Inc.
10.10.1 Company Overview
10.10.2 Pfiser Inc :Key Facts
10.10.3 Financial Performance
10.10.4 Product Benchmarking